🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our latest research has been accepted for presentation at #HeartFailure2025. Join us in Belgrade to see how EchoGo® and AI are advancing the detection of HFpEF and Cardiac Amyloidosis. Visit ultromics.com to know more. Presentation info ⤵️ Three Rules to Find Them All:

EchoGo® Amyloidosis can improve detection of patients with Cardiac Amyloidosis — an often-missed disease and a leading cause of Heart Failure. Dr. Faizi A. Jamal shares why this new tool is set to transform care and impact outcomes. Learn more: hubs.la/Q03m8_G20

We're at #HeartFailure2025! Our Director of Clinical Science @ presents: Three Rules to Find Them All – exploring how #AI supports #HFpEF management.📍 Moderated ePosters 3, 18 May, 12:00–12:45,

Ultromics featured research at Heart Failure 2025 📣 Our Director of Clinical Science Ashley Akerman presented: Three Rules to Find Them All: Clinical Risk Scores in Heart Failure With Preserved Ejection Fraction (HFpEF), highlighting the benefit of combining AI with traditional

Is this Cardiac Amyloidosis? Many heart conditions are challenging to detect, but AI can help uncover them. Dr. Patricia A. Pellikka shows how #EchoGo identifies disease from an echo videoclip: ultromics.com/harnessing-ai-… #CardioTwitter

Cardiac #Amyloidosis is a progressive, often underdiagnosed cause of #HeartFailure with serious impact on patient quality of life. Learn more about what Cardiac Amyloidosis is, how it’s diagnosed, and how it's treated: 👉 hubs.la/Q03prMW00

Cardiac #Amyloidos is frequently missed or diagnosed too late, often due to overlapping symptoms and limitations in current pathways. We break down why it’s challenging to diagnose — and the limitations of current tools. #CardioTwitter hubs.la/Q03qG0YY0

An Interview with Dr. Andres Schuster. Dr. Andres Schuster UH Harrington Heart & Vascular Institute on how Ultromics supports his team to seamlessly implement EchoGo® Heart Failure into workflow for #HFpEF care. uk01.l.antigena.com/l/Gl-S8kIhoCKs…

Patient symptoms aren’t matching the diastology? EchoGo® Heart Failure can help in the diagnostic process. Dr. Andres Schuster from UH Harrington Heart & Vascular Institute shares his experience using EchoGo® Heart Failure, powered by AI, to help detect #HFpEF. Read more in Cath Lab Digest:

EchoGo® Heart Failure detects #HFpEF with excellent sensitivity and specificity. Learn more about its impressive clinical performance in the new interview with Dr. Andres Schuster from UH Harrington Heart & Vascular Institute in this month’s Cath Lab Digest: hubs.la/Q03rTSzs0 #EchoFirst

In a new interview, Dr. Andres Schuster at UH Harrington Heart & Vascular Institute discusses recent cases where EchoGo® Amyloidosis supported the positive identification of patients with cardiac amyloidosis. Learn more how EchoGo® Amyloidosis, powered by #AI, identifies cardiac #amyloidosis, supporting